CoChat

A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration

Open access
Yamashiro, Kenji, Mori, Keisuke, Honda, Shigeru, Kano, Mariko, Yanagi, Yasuo, Obana, Akira, Sakurada, Yoichi, Sato, Taku, Nagai, Yoshimi, Hikichi, Taiichi, Kataoka, Yasushi, Hara, Chikako, Koyama, Yasurou, Koizumi, Hideki, Yoshikawa, Munemitsu, Miyake, Masahiro, Nakata, Isao, Tsuchihashi, Takashi, Horie-Inoue, Kuniko, Matsumiya, Wataru, Ogasawara, Masashi, Obata, Ryo, Yoneyama, Seigo, Matsumoto, Hidetaka, Ohnaka, Masayuki, Kitamei, Hirokuni, Sayanagi, Kaori, Ooto, Sotaro, Tamura, Hiroshi, Oishi, Akio, Kabasawa, Sho, Ueyama, Kazuhiro, Miki, Akiko, Kondo, Naoshi, Bessho, Hiroaki, Saito, Masaaki, Takahashi, Hidenori, Tan, Xue, Azuma, Keiko, Kikushima, Wataru, Mukai, Ryo, Ohira, Akihiro, Gomi, Fumi, Miyata, Kazunori, Takahashi, Kanji, Kishi, Shoji, Iijima, Hiroyuki, Sekiryu, Tetsuju, Iida, Tomohiro, Awata, Takuya, Inoue, Satoshi, Yamada, Ryo, Matsuda, Fumihiko, Tsujikawa, Akitaka, Negi, Akira, Yoneya, Shin, Iwata, Takeshi, Yoshimura, Nagahisa · 2017 · Scientific Reports
Cited by 35

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

We conducted a genome-wide association study (GWAS) on the outcome of anti-VEGF treatment for exudative age-related macular degeneration (AMD) in a prospective cohort. Four hundred and sixty-one treatment-naïve AMD patients were recruited at 13 clinical centers and all patients were treated with 3 monthly injections of ranibizumab followed by pro re nata regimen treatment for one year. Genomic DNA was collected from all patients for a 2-stage GWAS on achieving dry macula after the initial treatment, the requirement for an additional treatment, and visual acuity changes during the 12-month observation period. In addition, we evaluated 9 single-nucleotide polymorphisms (SNPs) in 8 previously reported AMD-related genes for their associations with treatment outcome. The discovery stage with 256 patients evaluated 8,480,849 SNPs, but no SNPs showed genome-wide level significance in association with treatment outcomes. Although SNPs with P-values of <5 × 10−6 were evaluated in replication samples of 205 patients, no SNP was significantly associated with treatment outcomes. Among AMD-susceptibility genes, rs10490924 in ARMS2/HTRA1 was significantly associated with additional treatment requirement in the discovery stage (P = 0.0023), and pooled analysis with the replication stage further confirmed this association (P = 0.0013). ARMS2/HTRA1 polymorphism might be able to predict the frequency of injection after initial ranibizumab treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-09632-0

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 35

Metadata

Authors
Yamashiro, K., Mori, K., Honda, S., Kano, M., Yanagi, Y., Obana, A., Sakurada, Y., Sato, T., Nagai, Y., Hikichi, T., Kataoka, Y., Hara, C., Koyama, Y., Koizumi, H., Yoshikawa, M., Miyake, M., Nakata, I., Tsuchihashi, T., Horie-Inoue, K., Matsumiya, W., Ogasawara, M., Obata, R., Yoneyama, S., Matsumoto, H., Ohnaka, M., Kitamei, H., Sayanagi, K., Ooto, S., Tamura, H., Oishi, A., Kabasawa, S., Ueyama, K., Miki, A., Kondo, N., Bessho, H., Saito, M., Takahashi, H., Tan, X., Azuma, K., Kikushima, W., Mukai, R., Ohira, A., Gomi, F., Miyata, K., Takahashi, K., Kishi, S., Iijima, H., Sekiryu, T., Iida, T., Awata, T., Inoue, S., Yamada, R., Matsuda, F., Tsujikawa, A., Negi, A., Yoneya, S., Iwata, T., & Yoshimura, N.
Venue
Scientific Reports
Published
2017-08-23
Volume
7
Issue
1
Pages
9196-9196
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2747264138
Cited by
35
References
13
FWCI
5.24
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration. https://app.cochat.ai/papers/10.1038/s41598-017-09632-0
The paper
Yamashiro, K., Mori, K., Honda, S., Kano, M., Yanagi, Y., Obana, A., Sakurada, Y., Sato, T., Nagai, Y., Hikichi, T., Kataoka, Y., Hara, C., Koyama, Y., Koizumi, H., Yoshikawa, M., Miyake, M., Nakata, I., Tsuchihashi, T., Horie-Inoue, K., . . . Yoshimura, N. (2017). A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration. Scientific Reports. https://doi.org/10.1038/s41598-017-09632-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.